Correlations of Plasma Biotinidase Levels with Hepatic Synthetic Functions in Children with Chronic Liver Diseases
Journal Title: International Journal of Biochemistry Research & Review - Year 2017, Vol 16, Issue 4
Abstract
Aims: Certain liver diseases can cause decreased synthesis of liver proteins or enzymes, including biotinidase, thereby reducing biotinidase activity in serum. The present study aimed to assess plasma biotinidase level in pediatric patients with compensated and decompensated chronic liver disease and to investigate the correlations between plasma biotinidase levels and the plasma albumin and prothrombin concentrations so that can identify the possible utility of plasma biotinidase levels as a predictor for hepatic synthetic function impairment . Methodology: A total of 29 pediatric patients (20 male and 9 female) with chronic liver disease were included in the study (16 compensated and 13 decompensated). Plasma albumin, prothrombin time and concentration were measured in the included patients. Assay of plasma biotinidase level was done by ELISA, using commercially available assay kit, for both patients and control group. Results: mean±SD of plasma biotinidase activities were found 4.4±1.2, 8.2±3, 8.7±0.7 IU\L (decompensated pediatric patients, compensated pediatric patients and control group respectively). Plasma biotinidase levels were statistically significant lower in pediatric patients with decompensated liver disease versus pediatric patients with compensated liver disease and control group (p˂0.001). There was statistically significant negative correlation between plasma biotinidase levels versus prothrombin time "PT" and international normalization ratio "INR" (p˂0.05) and statistically significant positive correlation between plasma biotinidase levels versus prothrombin concentration "PC" and albumin (p˂0.001). Conclusion: The findings of this study suggested that plasma biotinidase level could be used as a predictor for hepatic synthetic function impairment.
Authors and Affiliations
Tahia H. Saleem, Hamdy N. Eltalawy, Ahmed El-Abd Ahmed, Nagla H. Abu-Faddan, Mohammed H. Hassan, Ayat A. Sayed, Hussein M. Eldeeb
Keywords
Related Articles
- EP ID EP317082
- DOI 10.9734/IJBCRR/2017/32764
- Views 114
- Downloads 0
Cystatin C- An Early Diagnostic Biomarker of Diabetic Kidney Disease
Aim: This study aimed to evaluate serum cystatin C vs. Serum creatinine and BUN as a potential better marker for early diagnosis of diabetic kidney disease. Study Design: Cross-sectional study. Place and Duration of Stu...
Diagnostic Utility of Plasma Chitotriosidase, Total Acid Phosphatase Activity, Ferritin and Globulin Levels in Screening for Gaucher Disease
Aims: Gaucher disease "GD" is one of the most common glycolipid storage disorders. Several circulating molecules thought to be secreted by Gaucher cells have been studied as biological markers of disease. We investigate...
Disruption of Disulfide Bonds of Insulin Receptor as a Cause of Insulin Resistance in DM2
Many theories have been put forward to explain insulin resistance in DM2. The cause of insulin resistance still remained an enigma till date. Defect in insulin signaling pathway is one such possibility considered for ins...
Role of Pro-oxidant Myeloperoxidase and an Oxidative Stress Marker Malondialdehyde in Prediction of Preeclampsia
Aim of the Study: The treatment of preeclampsia (PE) is symptomatic till date, as the etiology of this condition has remained elusive for many centuries. Appreciating polymorphonuclear activation and oxidative stress as...
Effect of Enzyme Replacement Therapy on Disease Burden Biomarkers in Gaucher's Disease
Aims: We evaluate the effect of enzyme replacement therapy "ERT" on the plasma levels of some biochemical markers of the disease burden, in pediatric patients with Gaucher's disease "GD", in the form of plasma chitotrios...